Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Blood|January 24, 2015
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic featuresAlberto J Arribas, Andrea Rinaldi, Afua A Mensah, et al.
Frontiers in Oncology|June 14, 2021
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian SubstudyLidia Borghi, Gianantonio Rosti, Alessandro Maggi, et al.
The Journal of Experimental Medicine|June 15, 2011
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activationGiulia Fabbri, Silvia Rasi, Davide Rossi, et al.
Scientific Reports|December 1, 2020
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19Marco Vincenzo Lenti, Nicola Aronico, Ivan Pellegrino, et al.
Blood|June 24, 2016
The genetics of nodal marginal zone lymphomaValeria Spina, Hossein Khiabanian, Monica Messina, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Annals of Hematology|March 13, 2025
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian studyAlessia Castellino, Lorenzo Comba, Laura Bertolotti, et al.
Blood Advances|March 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana LinfomiRexhep Durmo, Stephane Chauvie, Federico Fallanca, et al.
Cancer Medicine|September 27, 2016
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markersMarco Lucioni, Emilio Berti, Luca Arcaini, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Pageof 25